Matches in SemOpenAlex for { <https://semopenalex.org/work/W4378783033> ?p ?o ?g. }
- W4378783033 endingPage "485" @default.
- W4378783033 startingPage "475" @default.
- W4378783033 abstract "Background: Osteosarcoma (OS) is an aggressive pediatric cancer with unmet therapeutic needs. Glutaminase 1 (GLS1) inhibition, alone and in combination with metformin, disrupts the bioenergetic demands of tumor progression and metastasis, showing promise for clinical translation. Materials and Methods: Three positron emission tomography (PET) clinical imaging agents, [18F]fluoro-2-deoxy-2-D-glucose ([18F]FDG), 3′-[18F]fluoro-3′-deoxythymidine ([18F]FLT), and (2S, 4R)-4-[18F]fluoroglutamine ([18F]GLN), were evaluated in the MG63.3 human OS xenograft mouse model, as companion imaging biomarkers after treatment for 7 d with a selective GLS1 inhibitor (CB-839, telaglenastat) and metformin, alone and in combination. Imaging and biodistribution data were collected from tumors and reference tissues before and after treatment. Results: Drug treatment altered tumor uptake of all three PET agents. Relative [18F]FDG uptake decreased significantly after telaglenastat treatment, but not within control and metformin-only groups. [18F]FLT tumor uptake appears to be negatively affected by tumor size. Evidence of a flare effect was seen with [18F]FLT imaging after treatment. Telaglenastat had a broad influence on [18F]GLN uptake in tumor and normal tissues. Conclusions: Image-based tumor volume quantification is recommended for this paratibial tumor model. The performance of [18F]FLT and [18F]GLN was affected by tumor size. [18F]FDG may be useful in detecting telaglenastat's impact on glycolysis. Exploration of kinetic tracer uptake protocols is needed to define clinically relevant patterns of [18F]GLN uptake in patients receiving telaglenastat." @default.
- W4378783033 created "2023-06-01" @default.
- W4378783033 creator A5003333805 @default.
- W4378783033 creator A5004034564 @default.
- W4378783033 creator A5007290763 @default.
- W4378783033 creator A5009907584 @default.
- W4378783033 creator A5016325742 @default.
- W4378783033 creator A5019853124 @default.
- W4378783033 creator A5031804038 @default.
- W4378783033 creator A5051328139 @default.
- W4378783033 creator A5067185494 @default.
- W4378783033 creator A5070280962 @default.
- W4378783033 creator A5075590318 @default.
- W4378783033 creator A5076216609 @default.
- W4378783033 creator A5076675210 @default.
- W4378783033 creator A5082080836 @default.
- W4378783033 creator A5084857988 @default.
- W4378783033 creator A5086675429 @default.
- W4378783033 date "2023-09-01" @default.
- W4378783033 modified "2023-09-27" @default.
- W4378783033 title "Exploration of Imaging Biomarkers for Metabolically-Targeted Osteosarcoma Therapy in a Murine Xenograft Model" @default.
- W4378783033 cites W1507543762 @default.
- W4378783033 cites W1578418351 @default.
- W4378783033 cites W1773238988 @default.
- W4378783033 cites W1968278602 @default.
- W4378783033 cites W1969649382 @default.
- W4378783033 cites W1986632212 @default.
- W4378783033 cites W1990050702 @default.
- W4378783033 cites W1999656185 @default.
- W4378783033 cites W2005616300 @default.
- W4378783033 cites W2011659954 @default.
- W4378783033 cites W2012076008 @default.
- W4378783033 cites W2028130370 @default.
- W4378783033 cites W2031861183 @default.
- W4378783033 cites W2036095734 @default.
- W4378783033 cites W2044731902 @default.
- W4378783033 cites W2052028442 @default.
- W4378783033 cites W2056207848 @default.
- W4378783033 cites W2060008081 @default.
- W4378783033 cites W2081029312 @default.
- W4378783033 cites W2084241693 @default.
- W4378783033 cites W2089963766 @default.
- W4378783033 cites W2098292062 @default.
- W4378783033 cites W2103342523 @default.
- W4378783033 cites W2105315565 @default.
- W4378783033 cites W2110239989 @default.
- W4378783033 cites W2112475025 @default.
- W4378783033 cites W2132117833 @default.
- W4378783033 cites W2150773292 @default.
- W4378783033 cites W2316444757 @default.
- W4378783033 cites W2329466375 @default.
- W4378783033 cites W2337308967 @default.
- W4378783033 cites W2400894239 @default.
- W4378783033 cites W2477757565 @default.
- W4378783033 cites W2543973826 @default.
- W4378783033 cites W2568298032 @default.
- W4378783033 cites W2576549964 @default.
- W4378783033 cites W2589122682 @default.
- W4378783033 cites W2756786254 @default.
- W4378783033 cites W2758367201 @default.
- W4378783033 cites W2769683012 @default.
- W4378783033 cites W2775097761 @default.
- W4378783033 cites W2778655320 @default.
- W4378783033 cites W2789813374 @default.
- W4378783033 cites W2887980667 @default.
- W4378783033 cites W2892650455 @default.
- W4378783033 cites W2921336769 @default.
- W4378783033 cites W2941514034 @default.
- W4378783033 cites W2943489129 @default.
- W4378783033 cites W2951399368 @default.
- W4378783033 cites W2965863523 @default.
- W4378783033 cites W2966831493 @default.
- W4378783033 cites W2979693741 @default.
- W4378783033 cites W3010778905 @default.
- W4378783033 cites W3049596762 @default.
- W4378783033 cites W4211048667 @default.
- W4378783033 doi "https://doi.org/10.1089/cbr.2022.0090" @default.
- W4378783033 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37253167" @default.
- W4378783033 hasPublicationYear "2023" @default.
- W4378783033 type Work @default.
- W4378783033 citedByCount "0" @default.
- W4378783033 crossrefType "journal-article" @default.
- W4378783033 hasAuthorship W4378783033A5003333805 @default.
- W4378783033 hasAuthorship W4378783033A5004034564 @default.
- W4378783033 hasAuthorship W4378783033A5007290763 @default.
- W4378783033 hasAuthorship W4378783033A5009907584 @default.
- W4378783033 hasAuthorship W4378783033A5016325742 @default.
- W4378783033 hasAuthorship W4378783033A5019853124 @default.
- W4378783033 hasAuthorship W4378783033A5031804038 @default.
- W4378783033 hasAuthorship W4378783033A5051328139 @default.
- W4378783033 hasAuthorship W4378783033A5067185494 @default.
- W4378783033 hasAuthorship W4378783033A5070280962 @default.
- W4378783033 hasAuthorship W4378783033A5075590318 @default.
- W4378783033 hasAuthorship W4378783033A5076216609 @default.
- W4378783033 hasAuthorship W4378783033A5076675210 @default.
- W4378783033 hasAuthorship W4378783033A5082080836 @default.
- W4378783033 hasAuthorship W4378783033A5084857988 @default.
- W4378783033 hasAuthorship W4378783033A5086675429 @default.